There are many factors that affect the passage of drugs through the blood-brain barrier and the blood-cerebrospinal fluid barrier. Generally, drugs used in the conventional treatments of many psychiatric disorders and central nervous system diseases are used to produce systemic effects. However, an increased dose or extended treatment time is required to achieve effective drug concentrations at the desired site. This significantly increases the risk of systemic toxicity. For this reason, methods of the direct delivery of drugs to the central nervous system without increasing their systemic concentration are being investigated intensively. Drug delivery methods to the central nervous system are divided into three groups non-invasive, invasive and alternative methods. Intranasal drug administration, which is one of the non-invasive methods that increase the solubility and permeability of the drug, prolongs the drug effects, minimizes enzymatic degradation, and increases the bioavailability of the drug, has become the focus of attention of researchers in recent years. However, the researchers' use of animal models to identify routes of nasal drug administration and potential brain targets limits the applicability of results to humans. In this review, the routes of intranasal drugs to the brain, the properties of drugs that can reach the central nervous system, and drug examples used in clinical trials are discussed.
Key words: Intranasal treatment; drug delivery; nose-brain pathway; blood-brain barrier.
|
